HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Massart, S. Articles by Ketelslegers, J.-M. Search for Related Content PubMed Articles by Massart, S. Articles by Ketelslegers, J.-M.

Administration of GH complexed with monoclonal antibodies (MABs) potentiates the in vivo actions of the hormone. In particular, growth and serum IGF-I concentrations of GH-treated hypophysectomized rats are increased by concomittant injection of anti-GH MABs. Among 37 anti-bovine GH (bGH) MABs, we selected one MAB with the most potentiating effects to investigate the mechanisms responsible for this phenomenon. Hypophysectomized rats were killed 18 h after a single s.c. injection of bGH (100 µg/rat), alone or complexed with increasing doses of MAB (4, 40, 400 µg/rat; MAB:bGH molar ratio: 0·005, 0·05, 0·5). IGF-I was measured by radioimmunoassay in acid–extracted sera and livers, whereas liver IGF-I mRNA was quantified by Northern blot hybridization. The in vivo occupancy of liver somatogenic (GH) receptors was derived from the determinations of total and free ¹²⁵I-labelled bGH binding to liver homogenates treated with 4 mol MgCl₂/l or water. Injection of MAB–bGH complexes enhanced body weight gain and raised serum IGF-I, liver IGF-I and liver IGF-I mRNA more than bGH alone (1·6-, 6-, 10- and 7-fold increases at the highest dose of MAB, compared with bGH alone; P < 0·001). These potentiating effects of the MAB were dose-dependent and significant potentiation of the growth response was already observed with the lowest dose of MAB. In vivo occupancy of liver GH receptors was markedly higher 18 h after injection of MAB–bGH complexes than after bGH alone, and this effect was also dose-dependent (receptor occupancy of 28%, 37% and 83% after 4, 40 and 400 µg of MAB respectively compared with 6% after bGH alone; P < 0·05, 0·05 and 0·001 respectively). In contrast, the in vitro binding of ¹²⁵I-labelled bGH to liver homogenates was decreased in the presence of high doses of MAB.

We conclude that low amounts of MABs complexed with bGH potentiate the stimulation by the hormone of liver IGF-I synthesis and secretion in a dose–dependent manner. These effects are mediated, at least in part, through changes in hormone-receptor interaction in vivo, leading to enhanced and/or prolonged binding of bGH to its somatogenic receptors.

Journal of Endocrinology (1993) 139, 383–393

This article has been cited by other articles:

				R. A. Hill, D. J. Flint, and J. M. Pell Antibodies as molecular mimics of biomolecules: roles in understanding physiological functions and mechanisms Advan Physiol Educ, December 1, 2008; 32(4): 261 - 273. [Abstract] [Full Text] [PDF]

				V. Beauloye, S. M. Muaku, P. Lause, D. Portetelle, R. Renaville, A. R. Robert, J. M. Ketelslegers, and D. Maiter Monoclonal antibodies to growth hormone (GH) prolong liver GH binding and GH-induced IGF-I/IGFBP-3 synthesis Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E308 - E315. [Abstract] [Full Text] [PDF]

				E. Stefanich, T. Senn, R. Widmer, C. Fratino, G.-A. Keller, and P. J. Fielder Metabolism of Thrombopoietin (TPO) In Vivo: Determination of the Binding Dynamics for TPO in Mice Blood, June 1, 1997; 89(11): 4063 - 4070. [Abstract] [Full Text] [PDF]